Comparing an Ayurvedic herbal vaginal suppository alone against its use with heat therapy for the treatment of cervical erosion

A Comparative Clinical Evaluation of Topical Nimbapatradi Varti with and without Agnikarma in Cervical Erosion. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113309

Enrollment

Registered

2026-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married women between 20 years to 45years age (Women Above 40 years without having any menopausal symptoms) 2 Patient having symptoms as Discharges per vagina, Contact bleeding, Lower abdomen pain, Dyspareunia as a chief complaint. 3 Cervical erosion present on per speculum examination. 4 Pap smear grading 1, 2.

Exclusion criteria

Exclusion criteria: 1 Pap smear grading 3, 4, 5. 2 Pregnant, lactating, menopausal women, 3 patient having condition like Abnormal uterine bleeding, Uterine prolapsed, benign growth of genital organ, Recent delivery (Duration of less then 3 months), Less then 3months of cauterization, Sexually transmitted disease. 3 Urinary tract infection (If pus cells more then 5). 4 Patient having Chronic systemic illness such as Tuberculosis, Hypertension, Diabetes mellitus, Renal disorder, Cardiac disease, Thyroid dysfunction, Malignancies, Pyrexia of unknown origin.

Design outcomes

Primary

Measure	Time frame
Change in the size and extent of cervical erosion as assessed via Per-Speculum.Timepoint: Baseline ( Day 0), Day 15, Day 30, Day 45 post-randomization	—

Secondary

Measure	Time frame
Improvement in the symptoms associated with cervical erosion, including dyspareunia, postcoital bleeding, vaginal discharges, and lower backacheTimepoint: Baseline ( Day 0), Day 15, Day 30, Day 45 post-randomization	—

Countries

India

Contacts

Public ContactDr Anjali Verma

Rishikul Campus Haridwar

drvermaanjali@gmail.com6398967773

Outcome results